Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.

    Feb 4, 2026DOI: 10.1093/cid/ciaf286Journal ArticleCID

    Written by: Chen WangBrenna A LaBereMichell M Lozano ChingaAnnalie J HarrisLindsey B RosenAmanda Elias RiveraEva Le RunKeith A SaccoWassim BallanJames V WoodwardScott A OstdiekMatthew W SmithVictoria L AndersonJanine R DaubCindy L PalmerLavenda Chirombo KluczynskiAndrew J OlerMagdalena A WalkiewiczRajarshi GhoshMorgan SimilukFariba M DonovanJohn WittNicolas BarrosL Joseph WheatJohn N GalgianiAlexandra F FreemanAmy P HsuChrista S ZerbeSteven M Holland

    Find these authors on Roon

    JG
    Dr. John Galgiani
    General ID · UACOMP

    Summary

    Refractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without signal transducer and activator of transcription 1 gain-of-function mutations.
    JGDr. John Galgiani

    Dr. John Galgiani

    Infectious Disease · General Infectious Disease
    University of Arizona College of Medicine- Phoenix
    johngalgiani